Immediate myeloid depot for SARS-CoV-2 in the human lung
Science Advances · 2024
DOI: 10.1126/sciadv.adm8836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Mélia Magnen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Angiotensin-Converting Enzyme 2, Lung. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
In the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, epithelial populations in the distal lung expressing Angiotensin-converting enzyme 2 (ACE2) are infrequent, and therefore, the model of viral expansion and immune cell engagement remains incompletely understood. Using human lungs to investigate early host-viral pathogenesis, we found that SARS-CoV-2 had a rapid and specific tropism for myeloid populations. Human alveolar macrophages (AMs) reliably expressed ACE2 allowing both spike-ACE2–dependent viral entry and infection. In contrast to Influenza A virus, SARS-CoV-2 infection of AMs was productive, amplifying viral titers. While AMs generated new viruses, the interferon responses to SARS-CoV-2 were muted, hiding the viral dissemination from specific antiviral immune responses. The reliable and veiled viral depot in myeloid cells in the very early phases of SARS-CoV-2 infection of human lungs enables viral expansion in the distal lung and potentially licenses subsequent immune pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
- Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.
- CoLabs Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.
- Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.
- Gladstone Institutes, San Francisco, CA 94158, USA.
- Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.
ORCID-Profile: Mélia Magnen, Arjun A Rao, Lauren Rodriguez, Olivier Bernard, Camille R Simoneau, Lisiena Hysenaj, Kenneth H Hu, Mazharul Maishan, Catharina Conrad, Oghenekevwe M Gbenedio, Bushra Samad, Prescott G Woodruff, David J Erle, Carolyn M Hendrickson, Michael A Matthay, Jeroen P Roose, Anita Sil, Melanie Ott, Charles R Langelier, Matthew F Krummel, Mark R Looney
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Magnen, M., You, R., Rao, A. A., Davis, R. T., Rodriguez, L., Bernard, O., Simoneau, C. R., Hysenaj, L., Hu, K. H., Maishan, M., Conrad, C., Gbenedio, O. M., Samad, B., Consortium, T. U. C., Love, C., Woodruff, P. G., Erle, D. J., Hendrickson, C. M., Calfee, C. S., …, & Looney, M. R. (2024). Immediate myeloid depot for SARS-CoV-2 in the human lung. Science Advances. https://doi.org/10.1126/sciadv.adm8836
Vancouver
Magnen M, You R, Rao AA, Davis RT, Rodriguez L, Bernard O, et al. Immediate myeloid depot for SARS-CoV-2 in the human lung. Science Advances. 2024. doi:10.1126/sciadv.adm8836
BibTeX
@article{Magnen2024,
author = {Magnen, Mélia and You, Ran and Rao, Arjun A and Davis, Ryan T and Rodriguez, Lauren and Bernard, Olivier and Simoneau, Camille R and Hysenaj, Lisiena and Hu, Kenneth H and Maishan, Mazharul and Conrad, Catharina and Gbenedio, Oghenekevwe M and Samad, Bushra and Consortium, The Ucsf Comet and Love, Christina and Woodruff, Prescott G and Erle, David J and Hendrickson, Carolyn M and Calfee, Carolyn S and Matthay, Michael A and Roose, Jeroen P and Sil, Anita and Ott, Melanie and Langelier, Charles R and Krummel, Matthew F and Looney, Mark R},
title = {Immediate myeloid depot for SARS-CoV-2 in the human lung},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adm8836}
}
EUVIMED